<DOC>
	<DOCNO>NCT01526317</DOCNO>
	<brief_summary>This clinical trial design compare pharmacokinetic characteristic combination separate administration Crestor ( Rosuvastatin ) Glucodown ( Metformin SR ) . Also investigate drug interaction separate combination administration . Total number subject 36 . 6 group ( 6 1 group ) , 3 period , consecutive 5 day administration , 10 day washout 5th day administration . All subject take Crestor alone , Glucodown alone , Crestor+Glucodown combination 3 period .</brief_summary>
	<brief_title>A Phase 1 Clinical Trial Investigate Pharmacokinetics Drug Interaction Crestor Glucodown OR SR Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>20~50 yr old , healthy Korean Subjects Body weight &lt; ideal body weight±20 % No congenital , chronic disease , No current disease Subjects diagnose include medical doctor laboratory ECG result . Subjects agree keep contraceptive method clinical trial . Subjects allergic investigational drug . Subjects medical history affect clinical trial . Hypertension ( Systolic BP ≥ 150mmHG Diastolic BP ≥ 100mmHg ) , Hypotension ( Systolic BP ≤ 100mmHg Diastolic BP ≤ 65mmHg ) Subjects take medicine recent 2~4 week . Subjects risk hypoglycemia imbalance take diet .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Drug interaction</keyword>
	<keyword>Rosuvastatin</keyword>
	<keyword>Metformin SR</keyword>
	<keyword>Pharmacokinetic</keyword>
</DOC>